Pharmacological Potential of Ginger (Zingiber officinale) in Migraine: A Systematic Review of Randomized Controlled Trials
- 1 September 2026
- journal article
- review article
- Published by A and V Publications in Research Journal of Pharmacy and Technology
- Vol. 19 (9) , 4014-4020
Abstract
Ginger (Zingiber officinale), a widely used medicinal plant, contains bioactive compounds such as 6-gingerol and 6-shogaol with anti-inflammatory, antioxidant, and antinociceptive properties. These pharmacological activities suggest a possible role in neurological disorders involving neuroinflammation and nociceptive activation. Migraine, one of the most common primary headache disorders, ranks among the leading causes of disability worldwide and is often difficult to manage with current pharmacological therapies, encouraging interest in herbal alternatives. This study systematically reviewed clinical evidence on the efficacy and safety of ginger for migraine. Literature searches were conducted in six electronic databases (PubMed, Scopus, ScienceDirect, SpringerLink, Cochrane Library, and Google Scholar) up to November 2024, following PRISMA guidelines and registered in PROSPERO. Eligible studies were randomized controlled trials (RCTs), and quality was assessed using the Cochrane RoB-2 tool. From 533 records, five RCTs involving 430 participants were included. Interventions consisted of capsules, tablets, and sublingual formulations (200–500 mg), compared with placebo or standard drugs such as sumatriptan, propranolol, and ketoprofen. Results were heterogeneous: some trials reported reductions in pain intensity or attack frequency, while others showed no significant differences (p >0.05). Adverse events were mainly mild gastrointestinal symptoms, and the suggested safe daily intake was ≤2 g. Overall, current evidence suggests that ginger may provide preliminary benefits in migraine management with a favorable short-term safety profile. This review indicates that ginger may provide modest benefits in migraine management with a good short-term safety profile. However, evidence is limited and inconsistent.Keywords
This publication has 29 references indexed in Scilit:
- Modulation of TRPV1 channel function by natural products in the treatment of painChemico-Biological Interactions, 2020
- Discovery of dual-acting opioid ligand and TRPV1 antagonists as novel therapeutic agents for painEuropean Journal of Medicinal Chemistry, 2019
- Ginger in gastrointestinal disorders: A systematic review of clinical trialsFood Science & Nutrition, 2018
- Capsaicin 8% Dermal Patch: A Review in Peripheral Neuropathic PainDrugs, 2018
- Current Prophylactic Medications for Migraine and Their Potential Mechanisms of ActionNeurotherapeutics, 2018
- A comparison between the effects of ginger, pyridoxine (vitamin B6) and placebo for the treatment of the first trimester nausea and vomiting of pregnancy (NVP)The Journal of Maternal-Fetal & Neonatal Medicine, 2017
- Is ginger effective for the treatment of irritable bowel syndrome? A double blind randomized controlled pilot trialComplementary Therapies in Medicine, 2014
- Comparison Between the Efficacy of Ginger and Sumatriptan in the Ablative Treatment of the Common MigrainePhytotherapy Research, 2013
- Ginger (Zingiber officinale) reduces acute chemotherapy-induced nausea: a URCC CCOP study of 576 patientsSupportive Care in Cancer, 2011
- Ginger (zingiber officinale) in migraine headacheJournal of Ethnopharmacology, 1990